Partnerships
Page 1 • 2 itemsDiscover global pharma partnerships driving innovation and market growth. Essential intelligence for BD, investors, and analysts.
Purdue Pharma Shutdown: $7.4B Deal Ends OxyContin Maker's Operations
Purdue Pharma, the manufacturer of OxyContin, is ceasing operations following a $7.4 billion settlement agreement. This landmark deal aims to address the company's role in the opioid crisis and provide compensation to victims.
Oncotelic Therapeutics Updates Partnership Strategy for Cancer Drug Development Pipeline
Oncotelic Therapeutics provides corporate update on strategic partnerships to advance clinical-stage cancer treatments and expand market reach.